Drug intelligence / Profile preview

telomestatin

Development stage
Preclinical
Lead developer
University of Tokyo
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

Telomestatin is a natural macrocyclic small molecule, originally isolated from the bacterium *Streptomyces anulatus*, that acts as a potent and selective stabilizer of G-quadruplex (G4) DNA structures. It specifically binds to and stabilizes the G-quadruplex formed at telomeric DNA repeats, which physically blocks the enzyme telomerase from accessing the telomere and extending it. This stabilization also leads to the displacement of the shelterin protein complex—including proteins such as Protection of telomeres protein 1 (POT1) and Telomeric repeat-binding factor 2 (TRF2)—that protects telomeres from being recognized as DNA double-strand breaks. Consequently, telomestatin induces telomere dysfunction, chromosomal end-to-end fusions, and rapid apoptosis in cancer cells while showing relatively low toxicity to normal cells. Although telomestatin itself has faced challenges in clinical development due to its poor solubility and difficult total synthesis, it has served as a foundational lead compound for the development of synthetic analogs by institutions such as Institut Curie.

02

Targets

telomeric G4 (Telomeric DNA G-quadruplex)TOP (DNA topoisomerases)POT1 (Protection of telomeres protein 1)TERT (Telomerase)

Beyond the preview

Go deeper on telomestatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on telomestatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call